Tag: venous thromboembolism

guideline

Updated VTE treatment guideline for patients with cancer revealed by ASCO

An updated guideline on the prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer has been unveiled by the American Society of...

Paediatric trial finds rivaroxaban similar to standard anticoagulation in treatment of...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from the Phase 3 EINSTEIN-Jr study, showing paediatric patients (aged birth to...

Increased risk of VTE found in critically ill H1N1 patients with...

A new study has found that intensive care unit patients with swine flu (H1N1) and acute respiratory distress syndrome (ARDS) were 33 times more...

Study finds significant association between low bilirubin levels and venous thromboembolism

A recent paper published by Hakan Duman (Recep Tayyip Erdoğan University, Rize, Turkey) and colleagues in the Journal of Vascular Surgery: Venous and Lymphatic...

BTG acquires Novate Medical

BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...

Cancer-associated VTE trial sees “lower rate of recurrent VTE with edoxaban...

Daiichi Sanyoko has announced the results from their Hokusai-VTE CANCER trial evaluating the direct oral anticoagulant edoxaban for treatment of venous thromboembolism (VTE) in...
Venous News

Inari Medical announces completion of enrolment in the FLARE study for...

Inari Medical has announced that it has completed enrolment of its investigational device exemption (IDE) study. The FlowTriever Pulmonary Embolectomy Clinical Study (FLARE) study...

More evidence that statins could prevent blood clots in the veins

Further evidence has been found by researchers at the UK’s University of Leicester and University of Bristol to suggest statins could "significantly reduce" the...

Canadian study finds rivaroxaban more effective at preventing recurrent blood clots...

A Canadian-led international research team has found that the blood thinner rivaroxaban is as safe as aspirin, and more effective at preventing recurrence of...
Venous News

Use of computerised systems may help identify patients at decreased risk...

The use of computerised clinical decision support systems among surgical patients are associated with a significant increase in the proportion of patients with adequately...
Venous News

First patient enrolled in Daiichi Sankyo European edoxaban registry

The first patient has been enrolled in Daiichi Sankyo’s EMIT-AF/VTE (Edoxaban Management in Diagnostic and Therapeutic Procedures) study. This registry will collect real-world clinical...